Please read the following information about this continuing education activity before accessing the presentations using links located at the bottom of this page.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (ACPE Activity #204-000-10-461-H01P).
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Society of Health-System Pharmacists designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. (Activity number 10810).
Educational Review Systems is an approved provider of continuing nursing education by the Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation (program number 05-115-10-097). This activity provides 1 hour of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida, and the District of Columbia.
For Nurse Practitioners
This program is approved for 1.0 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 1008278. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
For Case Managers
This program has been pre-approved by the Commission for Case Manager Certification (CCMC) to provide continuing education credit to Certified Case Managers (CCMs). This program is approved for 1 CEU.
Approval number: 790004165
Methods and Format
This is an online activity consisting of audio and slides for one presentation, a post-test, and an activity evaluation tool. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 1 hour. This activity is provided free of charge.
This continuing education activity was planned to meet the needs of physicians, pharmacists, nurses, nurse practitioners, and case managers. This activity is especially beneficial for health care professionals who are interested in improving the prevention of venous thromboembolism (VTE). Participants who are not familiar with the management of VTE are encouraged to complete two VTE essentials CE activities available as podcast or web-based on-demand activities entitled, "Multidisciplinary Approach to Identifying Patients at Risk for VTE" and "Managing VTE Prophylaxis: Making a Case for a Team Approach to Quality Improvement ."
Faculty will provide pearls and case examples to assist in VTE hospital quality improvement efforts. This activity will bring together the concepts addressed throughout the series, highlighting lessons learned and case examples from the trenches of VTE quality improvement.
After participating in this knowledge-based activity, participants should be able to
- Discuss clinical pearls in VTE prophylaxis quality improvement initiatives.
- Devise a plan and timeline for follow-up when implementing a VTE prophylaxis quality initiative.
Associate Professor of Pharmacy Practice
St. Louis College of Pharmacy
St. Louis, Missouri
Zachary A. Stacy, Pharm.D., BCPS, is Associate Professor of Pharmacy Practice at the St. Louis College of Pharmacy. He earned his Bachelor of Science degrees in chemistry and biology from Blackburn College and his Masters in Chemistry degree from Southern Illinois University in Edwardsville. Dr. Stacy completed his Doctor of Pharmacy degree at the St. Louis College of Pharmacy and a specialty residency in internal medicine at St. Luke's Hospital in Chesterfield, Missouri. He is a board-certified pharmacotherapy specialist. He maintains a clinical practice on the internal medicine and cardiology services at St. Luke's Hospital in Chesterfield.
Dr. Stacy's didactic responsibilities at the St. Louis College of Pharmacy include ischemic heart disease, hyperlipidemia, heart failure, peripheral arterial disease, and venous thromboembolism. He is an adjunct clinical professor in the Physician Assistant program at Saint Louis University and serves as an ACLS instructor. Dr. Stacy has received several teaching awards including the 2005 Excellence in Clinical Precepting Award, the 2009 Emerson Excellence in Teaching Award, and the 2009 Joe E. Haberle Outstanding Educator of the Year Award.
Dr. Stacy's primary research interests include the prevention of venous thromboembolism and the management of peripheral arterial disease. He has authored numerous articles, reviews, and book chapters on these topics and frequently provides presentations at state and national conferences. He is an active member of many pharmacy organizations including the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists.
In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support and the Accreditation Council for Pharmacy Education's Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals who have control in planning or presenting educational content disclose all relevant financial relationships with any commercial interest. This includes faculty, teachers, authors, activity directors, and members of planning committees. An individual has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speaker's bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the educational activity content over which the individual has control.The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage educational activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual's participation in development of content for an educational activity.
The faculty and planners report the following relationships:
Zachary A. Stacy, Pharm.D., BCPS
Dr. Stacy declares that he has served on the speakers bureau and is a consultant for sanofi-aventis.
Gregory A. Maynard, M.D., M.S.
Dr. Maynard declares that he has no relationships pertinent to this activity.
Stuart T. Haines, Pharm.D., BCPS
Dr. Haines declares that he is a stockholder for Merck and that his spouse is a consultant for Proctor and Gamble.
Cathy Bowles, B.S. Pharm.
Ms. Bowles declares that she has no relationships pertinent to this activity.
Susan R. Dombrowski, M.S., B.S. Pharm.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.
Kristi N. Hofer, Pharm.D.
Dr. Hofer declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
Zachary A. Stacy, Pharm.D., BCPS
*Allow additional time to complete the post-test and evaluation.
This activity is part of a tiered, multidisciplinary educational initiative and is designed to improve the care of patients at risk for VTE. For additional education and resources about this topic or to sign-up to be notified when new resources are available, visit www.StopVTE.org.
This activity is sponsored by the American Society of Health-System Pharmacists (ASHP) and
planned by ASHP Advantage, a division of ASHP.